In a December interview, NP gave the hint that mos
Post# of 148288
(Total Views: 609)
Posted On: 05/23/2020 1:00:44 PM
In a December interview, NP gave the hint that most of the regulatory milestone-payments are tailored around the payments due to AbbVie and Progenics upon BLA acceptance and approval. So, those milestone payments will mostly be used to cover those expenses.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼